PLoS ONE (Jan 2015)

Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease.

  • Gonçalo da Costa,
  • Cristina Ribeiro-Silva,
  • Raquel Ribeiro,
  • Samuel Gilberto,
  • Ricardo A Gomes,
  • António Ferreira,
  • Élia Mateus,
  • Eduardo Barroso,
  • Ana V Coelho,
  • Ana Ponces Freire,
  • Carlos Cordeiro

DOI
https://doi.org/10.1371/journal.pone.0125392
Journal volume & issue
Vol. 10, no. 7
p. e0125392

Abstract

Read online

Transthyretin amyloidosis is a conformational pathology characterized by the extracellular formation of amyloid deposits and the progressive impairment of the peripheral nervous system. Point mutations in this tetrameric plasma protein decrease its stability and are linked to disease onset and progression. Since non-mutated transthyretin also forms amyloid in systemic senile amyloidosis and some mutation bearers are asymptomatic throughout their lives, non-genetic factors must also be involved in transthyretin amyloidosis. We discovered, using a differential proteomics approach, that extracellular chaperones such as fibrinogen, clusterin, haptoglobin, alpha-1-anti-trypsin and 2-macroglobulin are overrepresented in transthyretin amyloidosis. Our data shows that a complex network of extracellular chaperones are over represented in human plasma and we speculate that they act synergistically to cope with amyloid prone proteins. Proteostasis may thus be as important as point mutations in transthyretin amyloidosis.